Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Chemical Biology & Drug Design
|
November 12, 2025
Transformer-Based Model for Drug Design and Therapy Response Prediction
Zheng Gu, Junxian Yu
Annals of Palliative Medicine
|
May 28, 2021
Immune checkpoint inhibitor-related pneumonitis induced by camrelizumab: a case report and review of literature
Ling Li, Anqi Lou, Junxian Yu
Current Cancer Drug Targets
|
April 20, 2013
Advances in translational pharmacological investigations in identifying and validating molecular targets of natural product anticancer agents
Junxian Yu, Subhasree A Nag, Ruiwen Zhang
Epigenomics
|
June 6, 2026
Machine learning models predict the immunotherapy response in tumors on the basis of DNA methylation
Zheng Gu, Ning Jiang, Erle Deng, et al.
Disease Markers
|
September 5, 2022
The Efficacy of Immune Checkpoint Inhibitors vs. Chemotherapy for KRAS-Mutant or EGFR-Mutant Non-Small-Cell Lung Cancers: A Meta-Analysis Based on Randomized Controlled Trials
Wei Chen, Ling Li, Sheng Cheng, et al.
The Clinical Respiratory Journal
|
April 2, 2024
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with KRAS mutations: A network meta-analysis
Lin Zhang, Wei Chen, Hongtao Wei, et al.
Bioscience, Biotechnology, and Biochemistry
|
January 1, 2020
Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapy
Yingjie Ma, Junxian Yu, Qin Li, et al.
BMC Cancer
|
August 23, 2023
Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression ≥ 50
Wei Chen, Jiayi Chen, Lin Zhang, et al.
Journal of Inflammation Research
|
April 25, 2023
Immune-Related Colitis Induced by Camrelizumab: A Case Report
Sheng Cheng, Yun Yang, Junxian Yu, et al.
Translational Cancer Research
|
March 12, 2026
Mature tertiary lymphoid structures tumor microenvironment-based risk model to assess patients with pancreatic ductal adenocarcinoma
Zheng Gu, Chaoran He, Sheng Cheng, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Chemical Biology & Drug Design
|
November 12, 2025
Transformer-Based Model for Drug Design and Therapy Response Prediction
Zheng Gu, Junxian Yu
Annals of Palliative Medicine
|
May 28, 2021
Immune checkpoint inhibitor-related pneumonitis induced by camrelizumab: a case report and review of literature
Ling Li, Anqi Lou, Junxian Yu
Current Cancer Drug Targets
|
April 20, 2013
Advances in translational pharmacological investigations in identifying and validating molecular targets of natural product anticancer agents
Junxian Yu, Subhasree A Nag, Ruiwen Zhang
Epigenomics
|
June 6, 2026
Machine learning models predict the immunotherapy response in tumors on the basis of DNA methylation
Zheng Gu, Ning Jiang, Erle Deng, et al.
Disease Markers
|
September 5, 2022
The Efficacy of Immune Checkpoint Inhibitors vs. Chemotherapy for KRAS-Mutant or EGFR-Mutant Non-Small-Cell Lung Cancers: A Meta-Analysis Based on Randomized Controlled Trials
Wei Chen, Ling Li, Sheng Cheng, et al.
The Clinical Respiratory Journal
|
April 2, 2024
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with KRAS mutations: A network meta-analysis
Lin Zhang, Wei Chen, Hongtao Wei, et al.
Bioscience, Biotechnology, and Biochemistry
|
January 1, 2020
Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapy
Yingjie Ma, Junxian Yu, Qin Li, et al.
BMC Cancer
|
August 23, 2023
Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression ≥ 50
Wei Chen, Jiayi Chen, Lin Zhang, et al.
Journal of Inflammation Research
|
April 25, 2023
Immune-Related Colitis Induced by Camrelizumab: A Case Report
Sheng Cheng, Yun Yang, Junxian Yu, et al.
Translational Cancer Research
|
March 12, 2026
Mature tertiary lymphoid structures tumor microenvironment-based risk model to assess patients with pancreatic ductal adenocarcinoma
Zheng Gu, Chaoran He, Sheng Cheng, et al.
Page
of 4